EIS Eczacibasi Ilac stock: EIS Eczacibasi Ilac files merger plans affecting its stock

EIS Eczacibasi Ilac filed a simplified merger application on September 24, 2026, involving its wholly owned Eczac?ba?? Gayrimenkul subsidiary. The move gives EIS Eczacibasi Ilac stock a corporate-structure catalyst while the company works through a weak first-half earnings picture, according to PDP.

Merger keeps capital unchanged

The transaction is planned as a simplified merger through acquisition of Eczac?ba?? Gayrimenkul Geli?tirme ve Yat?r?m A.?., which is fully owned by EIS Eczacibasi Ilac. The September 24, 2026 disclosure says the company will transfer the subsidiary's assets and liabilities at book value, using financial statements dated June 30, 2026.

The filing also specifies TRY 685.26 million of paid-in capital and zero capital increase connected with the acquisition. EIS Eczacibasi Ilac said the transaction would not require a general-meeting vote or create a shareholder withdrawal right, while the Capital Markets Board application was submitted on September 24, 2026.

What do the earnings show?

The merger arrives against a materially weaker operating period. For the first half of 2026, EIS Eczacibasi Ilac reported TRY 5.20 billion in sales and a TRY 1.90 billion net loss, compared with TRY 9.90 billion of annualized sales and TRY 2.50 billion of annualized net profit in the comparable 2025 series, according to Yatirimci AI. The same source lists quarterly second-quarter sales of TRY 2.40 billion, quarterly EBITDA of minus TRY 84.30 million and quarterly net loss of TRY 930.90 million for the period ending June 2026.

The latest available trading context places the stock at TRY 53.65 at the Borsa Istanbul close on October 21, 2026. That level was below the TRY 132.60 52-week high and above the TRY 51.90 low reported for the same historical-data window by Investing.com.

Dates investors can track

The chronology is clear: EIS Eczacibasi Ilac published its first-half financial reporting on August 6, 2026, filed the merger application on September 24, 2026, and most recently appeared in a Capital Markets Board notification list dated October 19, 2026. The next substantiated date is the June 30, 2026 financial-statement base used for the merger, while the filing itself remains the central corporate timetable.

Structure matters more than scale

The transaction does not add new shares or alter the stated paid-in capital, so its immediate significance is organizational rather than an expansion of the equity base. For investors, the key counterweight is the first-half loss and negative quarterly EBITDA, which make the eventual contribution from the absorbed property subsidiary important to the holding company's earnings profile.

EIS Eczacibasi Ilac is listed on Borsa Istanbul under ticker ECILC, with activities spanning healthcare, pharmaceuticals, personal care and real estate investments, according to Global Banking and Finance. The stock last closed at TRY 53.65 on October 21, 2026, below its TRY 132.60 52-week high.

Market context: Market report BIST 100.

More news and analyses on EIS Eczacibasi Ilac stock